Ginkgo Bioworks Holdings Price to Book Ratio 2020-2022 | DNA

Historical price to book ratio values for Ginkgo Bioworks Holdings (DNA) over the last 10 years. The current price to book ratio for Ginkgo Bioworks Holdings as of February 03, 2023 is 2.55.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Ginkgo Bioworks Holdings Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2023-02-03 2.06 2.36
2022-09-30 3.12 $0.87 3.57
2022-06-30 2.38 $0.96 2.48
2022-03-31 4.03 $1.00 4.05
2021-12-31 8.31 $0.97 8.54
2021-09-30 11.59 $1.09 10.65
2021-06-30 9.96 $0.07 137.57
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.996B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00